http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2290930-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c5540cfd579c591103ff87c13fc6491 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194 |
| filingDate | 2004-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26b65ac812c000de98c07ffcb605d519 |
| publicationDate | 2007-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2290930-C2 |
| titleOfInvention | Application of 2-ethyl-6-methyl-3-oxypyridine succinate for treatment of nephritis and nephropathy |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to application of 2-ethyl-6-methyl-3-oxypyridine succinate for treatment of nephritis and nephropathy of various ethiology in combination with conventional therapy including rheolytic, anticoagulant and antiaggregant agents, APP inhibitors and anti-inflammatory agents. n EFFECT: effective preparation for treatment of nephritis and nephropathy. n 2 tbl, 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020191502-A1 |
| priorityDate | 2004-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.